Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Prof Gueye reflects on his presidency at AORTIC 2011 in Cairo and how the organisation has progressed since the last meeting in 2009 and the Dakar Declaration.
By developing partnerships with organisations in United States such as ASCO, ACS and NCI and adopting the Dakar declaration, which focus on the current state of African healthcare and its improvement, Prof Gueye is optimistic about the future impact that AORTIC will have in combating cancer in Africa.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Use of bispecifics and CAR T cells in South America
Gaza's cancer patients: Navigating the dual struggle of illness and war
Laser oncosurgery - A new perspective in treating cancer
Cancer in emergencies: What can we do better to protect the most vulnerable?
Powering equity in cancer care through digital health
Navigating cancer treatment choices
Transforming childhood cancer treatment: key insights
Navigating breast cancer treatment for young patients